Company Quick10K Filing
Veeva Systems
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 159 $23,190
10-Q 2019-12-05 Quarter: 2019-10-31
10-Q 2019-09-05 Quarter: 2019-07-31
10-Q 2019-06-06 Quarter: 2019-04-30
10-K 2019-03-28 Annual: 2019-01-31
10-Q 2018-12-07 Quarter: 2018-10-31
10-Q 2018-09-06 Quarter: 2018-07-31
10-Q 2018-06-07 Quarter: 2018-04-30
10-K 2018-03-30 Annual: 2018-01-31
10-Q 2017-12-06 Quarter: 2017-10-31
10-Q 2017-09-07 Quarter: 2017-07-31
10-Q 2017-06-08 Quarter: 2017-04-30
10-K 2017-03-30 Annual: 2017-01-31
10-Q 2016-12-08 Quarter: 2016-10-31
10-Q 2016-09-08 Quarter: 2016-07-31
10-Q 2016-06-08 Quarter: 2016-04-30
10-K 2016-03-31 Annual: 2016-01-31
10-Q 2015-12-10 Quarter: 2015-10-31
10-K 2015-04-01 Annual: 2015-01-31
10-Q 2014-12-11 Quarter: 2014-10-31
10-Q 2014-06-06 Quarter: 2014-04-30
10-K 2014-03-18 Annual: 2014-01-31
10-Q 2013-12-13 Quarter: 2013-10-31
8-K 2019-11-26 Earnings, Exhibits
8-K 2019-11-01 M&A, Exhibits
8-K 2019-09-25 Enter Agreement, Regulation FD, Exhibits
8-K 2019-08-27 Earnings, Officers, Exhibits
8-K 2019-08-16 Officers, Exhibits
8-K 2019-06-20 Shareholder Vote
8-K 2019-05-29 Earnings, Exhibits
8-K 2019-04-01 Officers, Exhibits
8-K 2019-03-19 Officers
8-K 2019-02-26 Regulation FD
8-K 2019-02-26 Earnings, Exhibits
8-K 2019-02-22 Officers, Exhibits
8-K 2018-11-28 Earnings, Exhibits
8-K 2018-08-23 Earnings, Exhibits
8-K 2018-06-13 Shareholder Vote, Other Events, Exhibits
8-K 2018-06-07 Regulation FD, Exhibits
8-K 2018-05-24 Earnings, Exhibits
8-K 2018-02-27 Earnings, Regulation FD, Exhibits
8-K 2018-01-10 Officers

Veeva Systems Financials

VEEV Metrics, Comps, Filings

Annual | Quarterly

Business

Veeva is the leading provider of industry cloud solutions for the global life sciences industry. We were founded in 2007 on the premise that industry-specific cloud solutions could best address the operating challenges and regulatory requirements of life sciences companies. Our solutions are designed to meet the unique needs of our customers and their most strategic business functions-from research and development (R&D) to commercialization. Our solutions are designed to help life sciences companies develop and bring products to market faster and more efficiently, market and sell more effectively, and maintain compliance with government regulations.

Customer success is one of our core values, and our focus on it has allowed us to deepen and expand our strategic relationships with customers over time. Because of our industry focus, we have a unique, in-depth perspective into the needs and best practices of life sciences companies. This allows us to develop targeted solutions, quickly adapt to regulatory changes, and incorporate highly relevant enhancements into our existing solutions at a rapid pace.

Our goal is to become the most strategic technology partner to the life sciences industry and achieve long-term leadership with our solutions that support the R&D and commercial functions of life sciences companies. Our commercial solutions help life sciences companies achieve better, more intelligent engagement with healthcare professionals and healthcare organizations across multiple communication channels, including face-to-face, email, and web. Our R&D solutions for the clinical, regulatory, quality, and, when available, safety functions help life sciences companies streamline their end-to-end product development processes to increase operational efficiency and maintain regulatory compliance throughout the product lifecycle.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Activision Blizzard (ATVI) 35,351 21% 13.9 10% 17,495 5,518 7,426 1,549 1,685 2,415 33,452
Autodesk (ADSK) 34,134 87% 116.6 1% 4,873 5,067 3,005 2,619 57 297 34,600
Citrix Systems (CTXS) 30,974 86% 37.4 13% 3,935 3,427 3,002 2,567 528 814 30,469
Square (SQ) 30,173 41% 1,214.1 -1% 4,654 3,470 3,923 1,595 -53 25 30,429
Electronic Arts (EA) 29,643 74% 10.7 22% 9,749 3,264 5,022 3,728 2,147 2,439 26,110
Veeva Systems (VEEV) 23,190 73% 69.7 15% 1,860 415 969 707 288 321 22,362
Synopsys (SNPS) 21,200 78% 29.8 10% 6,153 2,214 3,305 2,577 626 692 20,637
Cadence Design Systems (CDNS) 19,514 0% 29.3 16% 2,612 1,182 2,304 0 426 645 18,880
Twilio (TWLO) 17,757 54% -122.3 -4% 5,109 812 881 476 -203 -141 17,222
Splunk (SPLK) 17,377 117% 119.4 0% 4,488 3,054 1,422 1,667 0 132 15,705
Ansys (ANSS) 17,172 89% 29.3 12% 3,513 696 1,391 1,239 438 565 16,541
Check Point Software (CHKP) 16,409 0% 5,828 2,056 0 0 0 0 16,105
SS&C Technologies (SSNC) 15,642 42% 18.8 2% 16,141 11,295 4,389 1,860 318 1,193 22,411
Tableau Software (DATA) 14,111 87% -104.9 -7% 1,912 837 1,231 1,077 -143 -129 13,558
Symantec (SYMC) 13,392 78% 20.0 1% 15,369 10,119 4,822 3,749 117 811 16,198
Take Two (TTWO) 12,686 42% 42.6 7% 4,366 2,280 2,821 1,187 308 260 11,074
Paycom (PAYC) 12,664 85% 52.7 9% 1,826 1,391 653 552 156 219 11,516
Okta (OKTA) 12,154 72% -80.6 -15% 1,027 776 487 352 -155 -148 11,936
DocuSign (DOCU) 10,891 75% -67.5 -13% 1,762 1,195 828 617 -233 -158 10,667
Ultimate Software (ULTI) 10,595 62% 81.9 2% 2,716 1,890 1,199 742 57 128 10,495

Balance Sheet ($MM)2014-01-312015-01-312016-01-312017-01-312018-01-312019-01-31
Cash2631291322183201
Accounts Receivable5893145183234303
Inventory
PP&E42847505255
Assets3705457069181,1971,654
Accounts Payable245679
Long-Term Debt
Liabilities90138201265325416
Stockholders' Equity2804075056538721,238
Income Statement ($MM)2014-01-312015-01-312016-01-312017-01-312018-01-312019-01-31
Revenue210313409544686862
Cost of Revenue83116142174211245
Gross Profit128198267370474617
R&D26416697132159
SG&A6286122166191235
Tax2122014179
Net Income24405469142230
Cash Flow ($MM)2014-01-312015-01-312016-01-312017-01-312018-01-312019-01-31
Cash Operating426880144233311
Cash Investing-27-272-97-97-155-104
Cash Financing2157119382126